Commentary
Commentaries are short perspectives by experts on AJKD articles or nephrology news.
Patients with kidney failure on maintenance hemodialysis are at higher risk of SARS-CoV2 infection and worse outcomes, spurring the urgent need for effective vaccination
[...]
Anemia has been recognized as a complication of chronic kidney disease (CKD) since the 1800s. The reasons for this are manifold and include erythropoietin deficiency, iron
[...]
Many of my personal patient encounters over the past years are near mirror images of the vignette discussed in a recent AJKD In Practice article from Rajora et al. A
[...]
A recent AJKD Core Curriculum from Vondracek et al tackles the broad topic of pharmacotherapy. In this piece, the authors discuss basic principles and give a comprehensive
[...]
Atrial fibrillation (AF) is the most common arrhythmia in patients with chronic kidney disease (CKD), with a prevalence of nearly 24.5%. This is over 2 times higher than
[...]
Lowering blood pressure (BP) is beneficial in patients with chronic kidney disease (CKD) from a cardiovascular protection point of view, and has formed the basis of our
[...]
Update: The Final Report was published on September 23, 2021. A Special Report published in AJKD highlights an interim report from the joint NKF/ASN Task Force on the
[...]
The emergence of direct acting antiviral (DAA) therapy for hepatitis C (HCV) has arguably been one of the most exciting developments in kidney transplantation in the United
[...]
Calcium channel blockers (CCBs) and renin-angiotensin-system inhibitors (RASi) are two classes of antihypertensive medications frequently used as initial therapy for
[...]
Phosphate is bad, right? As kidney function declines, phosphate excretion goes down. Serum phosphate levels rise, causing parathyroid hormone (PTH) to increase and bring
[...]